Category: OCR

  • OCR Guidance for Creating Short Study Title

    Due to database restrictions and the need for consistency among databases and departments, the Emory Office for Clinical Research (OCR) has developed guidance in creating the Short Study Title.  The Databases used to determine this guidance: OnCore, EPIC, Vestigo, ClinicalTrials.gov, Salesforce Study log, and eIRB submission.  The Short Study Title should be based upon the…

  • OnCore Training and SharePoint Updates

    As part of Emory Healthcare transitioning to the Epic electronic medical record and billing system, the University will be concurrently implementing the OnCore Clinical Trials Management System (CTMS) to provide a seamless connection for clinical research across the enterprise. OnCore is a cloud-based CTMS designed to simplify the management of clinical research and integration of…

  • Clinical Trials and the Advantage of a Feasibility Assessment

    In the Spring of 2019, the Emory University Office of the Senior Vice President for Research contracted with Huron Consulting Group to produce an analysis that examined business processes across the life cycle of a grant. The subsequent results of the analysis reported: “Clinical trials are not consistently required to go through a formal feasibility…

  • ClinicalTrials.gov Pre-Notice & Notice of Noncompliance

    The Food and Drug Administration (FDA) is taking action to ensure certain information in ClinicalTrials.gov is available to the public. On April 28, 2021, the FDA issued its first notice of non-compliance for failing to submit required results information. A Notice of Noncompliance indicates that the FDA has determined the Responsible Party (Principal Investigator) was…

  • Rapid Response Expedites COVID-19 Related Studies at Emory

    In January 2020, the Georgia CTSA Quality & Efficiency program finalized their SOP for the Rapid Response Team to obtain fast-track approvals across the Emory system. This new SOP allows for the coordination of needed approvals within 48 hours. The process was a collaboration, with Office for Clinical Research (OCR) leading Emory’s Rapid Response Team…

  • New Requirements for ClinicalTrials.gov

      Click here to learn about the new requirements for ClinicalTrials.gov.  

  • New ClinicalTrials.gov FDA regulation and NIH policy

    Written by: Jennifer Prozonic Office for Clinical Research  Changes and Impact of FDA Final Rule & NIH Policy for ClinicalTrials.gov In September of 2016, the U.S. Department of Health and Human Services issued a final rule expanding the scope of ClinicalTrials.gov and requiring additional registration and results reporting requirements to the existing Food and Drug…

  • Changes to Clinical Research Training

    You may have received a letter from Dr. Jeffrey Lennox, summarizing changes to the required training for researchers working on clinical trials. That training is now partially conducted via CITI, the same site that provides our IRB-required ethics training. However, until further notice, the IRB will still require your proof of completion to be uploaded…

  • Updated Clinical Trials Consent Template

    The Emory Biomedical, Grady, Children’s Healthcare of Atlanta, and Saint Joseph’s Hospital of Atlanta Consent/HIPAA templates have been updated. The new version date for all documents is 4-15-2016. Changes to the template include: A clarification to the guidance comments regarding medical records, Additional language for Cost Option 1 regarding what subjects may be liable for…

  • New ERMS Feature

    Effective 12/01/2015, a new feature was implemented in ERMS to allow study teams to track non-subject activities such as IRB fees, pharmacy fees, equipment, materials, record retention, dry ice, etc.  The new tracking feature in ERMS will appear under the Study tab as Non-Subject Activity.  For instructions, review the ERMS User Guide. Written By: Bridget…